Canakinumab as treatment for COVID-19-related pneumonia: a prospective case-control study. Generali D, Bosio G, Malberti F, Cuzzoli A, et al. Int J Infect Dis 2020 Dec 29. pii: S1201-9712(20)32597.

Read + Share

Amedeo Smart

Independent Medical Education

Generali D, Bosio G, Malberti F, Cuzzoli A, et al. Canakinumab as treatment for COVID-19-related pneumonia: a prospective case-control study. Int J Infect Dis 2020 Dec 29. pii: S1201-9712(20)32597.
PMID: 33385581